Audio

AHRQ identifies interventions, drugs that best target diabetic neuropathy

Author and Disclosure Information

Which interventions are linked with fewer amputations? Which ones are best for preventing ulcers? And which 2 drugs have the best evidence to support their use in treating the symptoms of this painful condition? Listen to this month’s audiocast and find out.


 

Recommended Reading

Telemedicine Boosts Number of Native Americans Who Can Obtain Retina Exams
Type 2 Diabetes ICYMI
DURATION-8: Exenatide/dapagliflozin efficacy holds up at 1 year
Type 2 Diabetes ICYMI
SPRINT: Intensive BP control cut cardiovascular risk in patients with prediabetes
Type 2 Diabetes ICYMI
FDA advisory committee supports new CV liraglutide indication
Type 2 Diabetes ICYMI
Oral insulin matches glargine in phase II trial
Type 2 Diabetes ICYMI
Nocturia and sleep apnea
Type 2 Diabetes ICYMI
LEADER post hoc analysis: Mechanism behind liraglutide’s cardioprotective effects unclear
Type 2 Diabetes ICYMI
Red flags for type 2 diabetes seen 25 years before diagnosis
Type 2 Diabetes ICYMI
Diabetes and obesity: Managing dual epidemics
Type 2 Diabetes ICYMI
Effect of Non–Insulin-Based Glucose-Lowering Therapies on Cardiovascular Outcomes in Patients With Type 2 Diabetes
Type 2 Diabetes ICYMI